Exact Sciences
360Dx Top 30 Starts the Year up 1 Percent
Of the 30 companies in the index, 22 saw their share prices increase while eight saw stock prices drop.
JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, QuidelOrtho, More
Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.
Exact Sciences Projects 28 Percent Bump in Total Q4 Oncology Revenue
The company expects to report consistent growth in both cancer screening and precision oncology testing for the quarter and the full fiscal year.
360Dx Top 30 Ends 2022 With 2 Percent Dip in December
Of the 30 companies in the index, nine saw their stock prices rise, while 21 firms' share prices decreased.
Investigators presented data from a meta-analysis that suggests the firm's POLAR gene expression test can identify patients unlikely to benefit from radiation.
Nov 3, 2022
Exact Sciences Q3 Revenues Rise 15 Percent
Aug 3, 2022
Jul 1, 2022
360Dx Top 30 Drops 5 Percent in June
Jun 14, 2022
Apr 26, 2022
Exact Sciences Q1 Revenues up 21 Percent
Apr 13, 2022
Feb 17, 2022